Rat Model Market worth $588.9 Million, at a CAGR of 8.7%
The CRISPR segment is expected to command the largest share of the global market.
Rat Model Market(firmenpresse) - The Rat Model Market is expanding with the increase in R&D activities in pharmaceutical industries. These rat models are being used in many applications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines).
What the Market Looks Like?
Predicted to grow at a CAGR of 8.7% during the forecast period, the global Rat Model Market is estimated to reach USD 588.9 Million by the end of 2021.
On the basis of type, the market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rat’s model. Knockout/genetically engineered rat’s segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of knockout/genetically engineered rat’s segment can be attributed to the use of this type of rat model to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s.
On the basis of services, the market is segmented into breeding, cryopreservation, quarantine, rederivation, model in-licensing, genetic testing, and others such as surgical services, line rescue services, and in vivo pharmacology services. The cryopreservation segment is estimated grow at the highest CAGR during the forecast period, as this segment help in obtaining the genetic material of rats even after the reproductive lifespan of these rats is over. This cuts down time and cost needed for reproduction of rats.
On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer technology, and others (genetically modified sperm-mediated gene transfer, Virus/vector-mediated gene transfer, Liposome-Mediated DNA Transfers, Electroporation of DNA, Biolistics, and TALENs & ZFN). The CRISPR segment accounted for the largest share of the Rat Model Market in 2016. The large share of this segment is mainly attributed to its ease of use and ability to multiply.
Download PDF Brochure (at) https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76036494
What Drives the Market?
The growth of the global market for Rat Model is primarily influenced by the following factors:
•Advancements in Gene Editing Tools Set to Augment the Demand for Rat Models
•Advantages Offered by Rats Over Mice
•Continuous Support in the Form of Investments and Grants
•Increased Demand for Personalized Humanized Rat Models Due to Growing Consumption of Personalized Medicines
•Increase in R&D Activities Carried Out by Pharmaceutical and Biotechnology Companies
DIABETES:
Rats are excellent experimental models for understanding the complex genetic basis of diseases such as diabetes. Due to the ever-increasing prevalence of diabetes globally; it has become important to study the mechanism of the disease. However, it is quite difficult to carry out research studies in human beings, owing to problems such as genetic heterogeneity and lack of controlled lifestyles. Rat models act as suitable models to study specific genetic mutations and to understand the function of genes on a homogeneous genetic background.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494
Geographical growth scenario of Rat Model Market;
•North America
•Europe
•Asia-Pacific
•Rest of the World
Leading market players and strategies adopted:
The prominent players in the Rat Model Market include Charles River Laboratories International (US), Envigo (UK), and Taconic Biosciences (US). Other players include Horizon Discovery Group (UK), genOway (France), Laboratory Corporation of America Holdings (US), Transposagen Biopharmaceuticals (US), Transviragen (US), Janvier Labs (France), and Biomere (US).
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.11.2019 - 08:20 Uhr
Sprache: Deutsch
News-ID 602671
Anzahl Zeichen: 4280
contact information:
Contact person: shelly singh
Town:
northbook
Phone: 18886006441
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 22.11.2019
Diese Pressemitteilung wurde bisher 182 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Rat Model Market worth $588.9 Million, at a CAGR of 8.7%"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
